Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

54.09

+0.59 (1.10%)

as of Jun 5, 2026, 3:10:33 pm Market Open.

1636 watching

Investor Insights

Jun 5, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by several analysts, who note its solid growth in Asia and the wealth management sector. The company is seen as a stable and reliable option, with a decent dividend yield that appeals to income-focused investors. Analysts acknowledge that while MFC has experienced some recent challenges, especially in its U.S. operations and corrections after strong performances, it maintains a healthy growth outlook. Concerns about the overall market and macroeconomic factors have led to suggestions of caution, but many believe MFC's valuation is still attractive relative to its peers, particularly the banks. In the long term, it remains a compelling investment opportunity with the potential for growth, other factors such as credit risk being minimal.

Consensus

Positive

Valuation

Fair Value

Similar

SLF

Premium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK

Stockchase Research Editor: Michael O'Reilly As one of Canada's largest financial and insurance providers, we again reiterate MFC as a TOP PICK. Recently reported earnings missed expectations, due to higher than expected mortality rates in the US due to COVID. However, moving forward the company recently de-risked a sizable portion of their US annuity business that frees up over $2 billion in capital. Higher interest rates will also benefit the company. It trades at only 5x earnings, supports a ROE over 18% and is valued just under book. It pays a healthy dividend, backed by a payout ratio under 30%. We continue to recommend a stop loss at $21.50, looking to achieve $28 -- upside potential over 18%. Yield 5.6% (Analysts’ price target is $27.67)

BUY

Insurance companies usually benefit from rising rates. Global company. Financials are attractive, as he expects the yield curve to normalize over the next year or two.

Premium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK

Stockchase Research Editor: Michael O'Reilly With a market cap of $50 billion, MFC is one of Canada's largest financial services firms. It is in a space that tends to benefit from rising interest rates and we reiterate it as TOP PICK. It trades right at book value and at 7x earnings, it is good value here. The dividend was recently bumped up over 17% and is backed by a payout ratio under 35% of cash flow. We are recommend to slide the stop (down from $24.50) to $21.50, to accommodate current market uncertainty, looking to achieve $30 -- upside potential over 20%. Yield 5.19% (Analysts’ price target is $30.00)

DON'T BUY

They take on too much risk and the dividend doesn't make him buy.

PAST TOP PICK

(A Top Pick Apr 21/21, Down 1%) At close to book value, better priced today than SLF, which also has a lower yield. Large exposure to Asia's continuing Covid situation may explain lagging performance. Extremely well structured and financed. No hesitation in recommending it long term. Yield slightly over 5%.

Premium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK

Stockchase Research Editor: Michael O'Reilly As one of Canada's largest insurers, with rapidly growing operations in the US and Asia, we again reiterate MFC as a TOP PICK. Recently reported earnings again beat analyst expectations and support a respectable 14% ROE, which helps support a great dividend yield that employs less than 35% of cash flow. It trades at 8x earnings, compared to peers at 33x. We recommend trailing up the stop (from $21.00) to $24.50, looking to achieve 31.50 -- 15% upside potential. Yield 4.84% (Analysts’ price target is $31.33)

BUY

Great Asian franchise. Asset management business has been tough, decreasing margins. Will continue to do better, especially as we see less volatility. Worth owning here. Nice yield of almost 5%, not trading at a huge multiple at 1.2x book.

WEAK BUY

A pocket of value in the sector, life insurance is the cheapest in the group. Lifecos definitely have room for multiple expansion and earnings growth. His preferred name is GWO, with a more mature M&A market focus. MFC is more focused on EM.

DON'T BUY

It's so tough here. He ranks it negatively. The financial health of MFC is poor. If it breaks below $25.43, watch out. It yield 4.9%, but he is worried about financials trading at these levels. There's something wrong with their balance sheet, but he hasn't done a deep dive on it. Sell if it falls to $24.50. Doesn't see an upside here, just the dividend.

PARTIAL SELL

A stellar performance in the last 6 months with strong dividend growth in the past year. But slower economic activity in Asia is a headwind. Take profits or sell, then re-enter in the summer on a 10-15% pullback. He likes the dividend.

COMMENT

Hasn't been a growth story. When an insurance company writes an insurance policy, they have a long term liability. They need to earn a rate of return. 5-6 years, there hasn't been growth. Likes it and owns it below $20-$25. Does not want to own it around $30.

BUY ON WEAKNESS

Defensive, modest beats, clean last quarter, doing well in Asia, incredibly cheap, decent growth rate. Sort of like that cough syrup commercial, "You might not like it, but it works." Has severely underperformed. Accounting standards headwinds. Trades at 6x with a 10% growth rate. Whippy stock, you can probably purchase under $25 or 24.50.

SELL ON STRENGTH

Allan Tong’s Discover Picks MFC pays a safe dividend, too (at a 32.98% payout ratio), but it’s even higher at 5.16%. Mind you, the street has a bullish forward PE of 11.91x on SLF, so the street believes in the company’s growth. Profit margins of both insurers are virtually the same around 11.5%, but MFC trades at a lower PE of 7.3x. However, MFC shares can never breach $28, despite consistent price targets as high as $30. Why, I don’t know, but the charts are there to see. Read 4 Promising TSX Stocks for our full analysis.

HOLD

Good company, nice dividend. Asian franchise is really strong, which will add growth over the long term, but is adding volatility right now. Not paying a lot for it, either on PE or price to book. Nice story to have.

HOLD

Sell MFC and buy BNS? Is watching the impact of Hong Kong on MFC. She prefers owning Canadian banks to lifecos. MFC trades at a discount to the group. Manager continue to rectify past company mistakes. The dividend is safe. She does own BNS.

Showing 181 to 195 of 2,279 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)

Unlock this Panic-proof Portfolio opinion with Stockchase Premium